Abstract
The International Harmonization of Nomenclature and Diagnostic Criteria for Lesions in Rats and Mice proposal (INHAND) has been operational since 2005. A Global Editorial Steering Committee manages the overall objectives of the project, and the development of harmonized terminology for each organ system is the responsibility of the Organ Working Groups, drawing upon experts from North America, Europe, and Japan. Great progress has been made with 9 systems published to date—respiratory, hepatobiliary, urinary, central/peripheral nervous systems, male reproductive and mammary, zymbals, clitoral, and preputial glands in
Standardization of microscopic pathology nomenclature and diagnostic criteria, especially for rats and mice, has been under discussion for many years by pathologists in the profession of toxicologic pathology. In 2005, the Society of Toxicologic Pathology (STP) and European Society of Toxicologic Pathology (ESTP), along with Registry of Industrial Toxicology Animal-data (RITA), established a collaborative process to review, update, and harmonize existing nomenclature documents and databases. The British Society of Toxicologic Pathology (BSTP) and the Japanese Society of Toxicologic Pathology (JSTP) joined the project in 2006, making this a genuinely global initiative. The result of these discussions was the International Harmonization of Nomenclature and Diagnostic Criteria for Lesions in Rats and Mice proposal (INHAND). A Global Editorial Steering Committee (GESC) manages the overall objectives of the project, and working groups (WGs) formulate the terminology proposals for each organ system (Vahle et al. 2009). Both the GESC and the WGs are composed of experts from the North American, British, European, and Japanese Societies of Toxicologic Pathology.
Noteworthy headway has been made with 9 systems to date. Rodent respiratory, hepatobiliary, urinary, central/peripheral nervous systems, male reproductive and mammary, zymbals, clitoral, and preputial glands have been published in
INHAND and GESC will continue current Organ Working Groups (OWGs) until publication of all systems is complete. The remaining rodent systems include digestive, cardiovascular, skeletal, endocrine, special senses, and lymphoid/hematopoietic. In order to establish the format and style that would be suitable for the content of these nomenclature guides, the STP supported the publication of the first several systems in
Nonrodent Terminology
In addition to terminology for rodents, a new directive for separate committees to develop species-specific terminology has been established under GESC—dog, monkey, rabbit, and minipig. Committees are reviewing the rodent nomenclature as the starting point and then providing a manuscript on terminology that is in common use in each species, terminology that is unique for each species as well as rodent terminology not appropriate for use in nonrodent species. This information will be posted on goRENI. Publication as an article or supplement will be determined on a case-by-case basis.
Relationship between INHAND and Standard for Exchange of Nonclinical Data (SEND)
During 2012, INHAND GESC representatives attended meetings with representatives of the Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER), Clinical Data Interchange Standards Consortium (CDISC), and the National Cancer Institute (NCI) Enterprise Vocabulary Services (EVS) to initiate integration of INHAND terminology as the preferred terminology for SEND. SEND is a formal mechanism for submitting data from nonclinical studies to the FDA electronically and in a standardized format. INHAND GESC assists the SEND Controlled Terminology (CT) committee in providing definitions for base processes and modifiers associated with the INHAND published terminology. INHAND ad hoc members of the SEND CT committee will participate in this endeavor and take issues to the full GESC and/or appropriate OWG for resolution. The GESC may also call on experts in the field to assist in any aspect of their role as a “Scientific Advisory Board.” The interest in utilizing the INHAND nomenclature, based on input from industry and government toxicologists as well as information technology specialists, signifies the potential for wide acceptance of this nomenclature (Keenan and Goodman 2014).
GESC will become a permanent standing committee of the various STPs with a defined appointment and term of members and establishment of several new roles, due to the expectation for ongoing interactions with the SEND project and future needs to serve in an advisory role. GESC will act as a clearinghouse for comments and requests for updates to the INHAND terminology from the SEND CT committee as well as from the memberships of each Society.
INHAND as an Ongoing Process
Although the published INHAND nomenclature for each organ system is expected to be very comprehensive, it is recognized that additional lesions may need to be included, omissions rectified, or inaccuracies corrected as they become apparent. To address this, a formal change control process was implemented in 2013 and is available on www.goreni.org and each Society Web site. Society members are encouraged to submit suggestions for changes to the nomenclature systems and provide justifications for such changes through this mechanism. GESC will continue to interface with goRENI and editorial staff at the journals, so that the basic structure for future publications is maintained.
The GESC and STP, BSTP, ESTP, and JSTP leadership greatly appreciate the efforts of all those serving on the OWGs and the newly formed nonrodent WGs, and look forward to working with the global toxicologic pathology community as additional systems are drafted, reviewed, and completed. The international scope and review of the INHAND documents will provide a strong framework for use by pathologists and regulatory agencies that are engaged in the safety assessment of drugs, biologics, and chemicals.
Footnotes
Author Contribution
C. M. Keenan, J. Baker, A. Bradley, D. G. Goodman, T. Harada, R. Herbert, W. Kaufmann, R. Kellner, B. Mahler, E. Meseck, T. Nolte, S. Rittinghausen, J. Vahle, and K. Yoshizawa contributed to conception or design; data acquisition, analysis, or interpretation; drafted the manuscript; and critically revised the manuscript. All authors gave final approval and agreed to be accountable for all aspects of work in ensuring that questions relating to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
The author(s) received no financial support for the research, authorship, and/or publication of this article.
